#ICYMI: We announced the enrollment completion of the Phase 2b ARISE-AD Study evaluating our investigational BTLA agonist in people living with #AtopicDermatitis. Our thanks to all who have helped us reach this milestone in our ongoing work to deliver innovative immunology therapeutics to those living with #Autoimmune and #InflammatoryDiseases. $ANAB #ClinicalTrial #ClinicalTrialEnrollment
AnaptysBio
Biotechnology Research
San Diego, California 9,414 followers
Transforming patient health by delivering innovative immunology therapeutics.
About us
AnaptysBio ($ANAB) is a clinical-stage biotechnology company focused on transforming patient health by discovering and developing innovative immunology therapeutics. Our broad portfolio of immune cell modulators includes two checkpoint agonists in clinical-stage development. We are dedicated to making a difference in the lives of people living with autoimmune and inflammatory diseases.
- Website
-
https://www.anaptysbio.com
External link for AnaptysBio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Diego, California
- Type
- Public Company
- Founded
- 2005
- Specialties
- Antibodies, Cancer immunotherapy, Inflammation, and Immunology
Locations
-
Primary
10770 Wateridge Circle
Suite 210
San Diego, California 92121, US
Employees at AnaptysBio
Updates
-
Today, we announced our #Q2 earnings and provided an update on our work to develop immune cell modulators for patients living with #Autoimmune and #InflammatoryDiseases. Read our full announcement: https://bit.ly/46Hqxcw #Q2Earnings $ANAB
-
At the heart of our vision to transform patient health through innovative immunology therapeutics are three core values that guide our actions. Learn more: https://lnkd.in/g5yXUb66 #WeAreAnaptysBio #CompanyCulture #CompanyValues
-
It doesn’t take a scientist to understand our science! "Short Takes on Deep Science” offers bite-sized, expert perspectives on the latest in immune cell modulation and therapeutic innovation for #Autoimmune and #InflammatoryDiseases. Listen now at https://lnkd.in/eVM7G9DQ
-
Did you know an estimated four in 10 people living with #RheumatoidArthritis (RA) do not achieve disease remission with the current standard of care? Learn more about RA and our ongoing research evaluating a potential new treatment option.
-
If you or someone you know is looking for a potential new treatment option for #UlcerativeColitis (UC), take a moment to learn about the ROSETTA Study, a clinical trial of an investigational medicine. This study is currently enrolling. Learn more: https://bit.ly/3XJ7trL #ClinicalTrialEnrollment #ClinicalTrials
-
-
Today, we’re shining the spotlight on William T., Senior Scientist 1. Thank you, William, for sharing your positive energy and commitment to great science with us! #WeAreAnaptysBio #CompanyCulture
-
Nothing beats a day on the water with this team! Earlier this week, we celebrated #EmployeeAppreciationDay with our annual all-employee cruise around the beautiful San Diego Bay. The time spent together was priceless. #WeAreAnaptysBio #TeamMemberAppreciation
-
-
🎉 Join us in welcoming Sapna Kabaria, M.D., Nicole Rodrigues, Stefanie Unger, and Giles Hulley to Team Anaptys! Sapna, Nicole, Stefanie, and Giles, we’re so glad to have each of you on board and look forward to achieving great things together. #WeAreAnaptysBio #NewHires
-
In honor of #EmployeeWellnessMonth, we’re spotlighting the connection between work and overall well-being. Take a moment to learn how members of Team Anaptys prioritize their health during the work week. #WeAreAnaptysBio #EmployeeWellness #SelfCare